Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      

13th World Congress on Cancer Science & Therapy

https://cancer-events.com/

Categories

Date of beginning

Wednesday, 02 December 2026

Duration

2 days

Deadline for abstracts

Thursday, 31 December 2026

City

rome

Country

Italy

Contact

+1-662-601-8380

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Expected participants

200

Memo

It is our great pleasure to welcome you to the 13th World Congress on Cancer Science & Therapy, which will be held on August 02-03, 2027, in Rome, Italy. The conference will emphasize the theme: “Harnessing Artificial Intelligence to Transform Cancer Science, Precision Diagnosis and Personalized Therapy” Cancer Science & Therapy 2027 provides a global platform for oncologists, clinicians, researchers, healthcare professionals, academicians, and industry leaders to gather, exchange knowledge, and advance innovative strategies for cancer prevention, diagnosis, treatment, and patient care worldwide. The 13th World Congress on Cancer Science & Therapy will serve as a premier international forum for advancing the future of cancer research and clinical care through scientific excellence, interdisciplinary collaboration, and transformative innovation. The congress will showcase the latest research findings, evidence-based clinical practices, and technological advancements that are reshaping the diagnosis, treatment, and management of cancer. Bringing together medical oncologists, radiation oncologists, surgical oncologists, cancer researchers, pathologists, radiologists, hematologists, nurses, healthcare policymakers, and experts from the pharmaceutical and biotechnology sectors, the event will foster meaningful dialogue on emerging therapies, precision oncology, immunotherapy, targeted treatments, artificial intelligence, digital health solutions, and preventive strategies. Through the exchange of knowledge and best practices, participants will work collectively to address global cancer challenges, improve clinical outcomes, and promote better quality of life for cancer patients and survivors.